UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2024

 

OR

 

TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to _________

 

Commission File Number: 000-28675

 

SAXON CAPITAL GROUP, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   94-3370795
(State or Other Jurisdiction of
Incorporation or Organization)
 

(I.R.S. Employer

Identification No.)

     
PO Box 147165, Lakewood, Colorado   80214
(Address of Principal Executive Offices)   (Zip Code)

 

303-323-4896

(Registrant’s telephone number, including area code)

 

_______________________________________________________ 

(Former Name, former address and former fiscal year, if changed since last report)

 

Securities registered under Section 12(b) of the Exchange Act: None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes     No 

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes     No 

 

 
 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer, ” "non-accelerated filer ,"  “ smaller reporting company, ” and “ emerging growth company ” in Rule 12b-2 of the Exchange Act. (Check one):

 

 

Large accelerated filer [_] Accelerated filer [_]
Non-accelerated filer [X] Smaller reporting company [X]
  Emerging growth company [X]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes     No 

  

As of May 15, 2024, there were 14,981,701,785 shares of common stock, $0.00001 par value per share, outstanding. 

 

 

 

 

 

 
 

 

 

 

TABLE OF CONTENTS

 

    Page
PART I – FINANCIAL INFORMATION  
Item 1. Financial Statements 1
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 13
Item 3. Quantitative and Qualitative Disclosures About Market Risk 18
Item 4. Controls and Procedures 18
     
PART II – OTHER INFORMATION  
Item 1. Legal Proceedings 20
Item 1A. Risk Factors 20
Item 2. Unregistered Sale of Equity Securities and Use of Proceeds 20
Item 3. Defaults Upon Senior Securities 20
Item 4. Mine Safety Disclosures 20
Item 5. Other Information 20
Item 6. Exhibits 21
     
SIGNATURES 22

 

 

 
 

PART I

Item 1. Financial Statements.

 

SAXON CAPITAL GROUP, INC.
 
CONDENSED BALANCE SHEETS
       

 

  

MARCH 31,

2024

(Unaudited)

  DECEMBER 31, 2023
ASSETS          
           
Current Assets          
Cash and Cash Equivalents  $
—  
   $
—  
 
Total Current Assets   
—  
    
—  
 
           
Total Assets  $
—  
   $
—  
 
           
 LIABILITIES AND SHAREHOLDERS' DEFICIT          
           
Current Liabilities          
Accounts Payable  $1,855   $1,600 
Accruals - Related Parties   249,000    234,000 
Note Payable - Related Party   104,931    104,506 
           
Total Current Liabilities   355,786    340,106 
           
Total Liabilities   355,786    340,106 
           
Commitments and Contingencies (Note 7)   
 
    
 
 
           
Shareholders' Deficit          
Preferred Stock, $0.00001 par value, 24,999,000 shares authorized as of March 31, 2024 and December 31, 2023.   
—  
    
—  
 
Series A Preferred Stock, $0.00001 par value,1,000 shares authorized, 501 shares issued and outstanding as of March 31, 2024 and December 31, 2023   19,990    19,990 
Common Stock, $0.00001 par value, 15,000,000,000 shares authorized, 14,981,701,785 shares issued and outstanding as of March 31, 2024 and December 31, 2023   149,817    149,817 
Additional Paid In Capital   30,635,942    30,635,942 
Accumulated Deficit   (31,161,535)   (31,145,855)
           
Total Shareholders’ Deficit   (355,786)   (340,106)
           
Total Liabilities and Shareholders' Deficit  $
—  
   $
—  
 
           
The accompanying notes are an integral part of these condensed unaudited financial statements.
           

 

1 

 

SAXON CAPITAL GROUP, INC.
 
CONDENSED UNAUDITED STATEMENT OF OPERATIONS

 

       
   FOR THE THREE MONTHS ENDED
MARCH 31,
   2024  2023
       
REVENUE  $
—  
   $
—  
 
           
OPERATING EXPENSES:          
           
General and administrative expenses   15,680    27,279 
Total Operating Expenses   15,680    27,279 
           
OPERATING LOSS   (15,680)   (27,279)
           
OTHER INCOME (EXPENSE)   
—  
    
—  
 
           
LOSS BEFORE TAXES   (15,680)   (27,279)
           
TAXES   
—  
    
—  
 
           
NET LOSS  $(15,680)  $(27,279)
           
Net Loss per Common Shares Outstanding – Basic and Diluted
  $(0.00)  $(0.00)
           
Weighted Average Common Shares Outstanding – Basic and Diluted
   14,981,701,785    14,981,701,785 
           
           
The accompanying notes are an integral part of these condensed unaudited financial statements.
           

 

  

2 

 

 

SAXON CAPITAL GROUP, INC.
 

CONDENSED UNAUDITED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND 2023

 
                     

 

   Series A Preferred Shares  Common Shares         
   Shares  Amount  Shares  Amount  Additional Paid-In Capital  (Accumulated Deficit)  Total
                      
Balance at December 31, 2023   501   $19,990    14,981,701,785   $149,817   $30,635,942   $(31,145,855)  $(340,106)
                                    
Net loss for the period   —      
—  
    —      
—  
    
—  
    (15,680)   (15,680)
                                    
Balance at March 31, 2024   501   $19,990    14,981,701,785   $149,817   $30,635,942   $(31,161,535)  $(355,786)
                                    
Balance at December 31, 2022   501   $19,900    14,981,701,785   $149,817   $30,635,942   $(31,053,631)  $(247,882)
                                    
Net loss for the period   —      
—  
    —      
—  
    
—  
    (27,279)   (27,279)
                                    
Balance at March 31, 2023   501*  $19,900    14,981,701,785   $149,817   $30,635,942   $(31,080,910)  $(275,161)
                                    
                                    

 

The accompanying notes are an integral part of these condensed unaudited financial statements.

 

 

 

 

 

 

3 

 

 

SAXON CAPITAL GROUP, INC.
 
CONDENSED UNAUDITED STATEMENTS OF CASH FLOWS
 
 
   FOR THE THREE MONTHS ENDED
   MARCH 31,
   2024  2023
Cash Flows from Operating Activities:          
Net Loss  $(15,680)  $(27,279)
Adjustments to reconcile net loss to net cash used in operating activities:   —      —   
           
Changes in working capital items:          
           
Accounts Payable and Accruals   255    (1,675)
Accruals - Related Parties   15,000    15,000 
           
Net Cash Flows Used in Operating Activities   (425)   (13,954)
           
Net Cash Flows from Investing Activities   
—  
    
—  
 
           
Cash Flows from Financing Activities          
Note Payable - Related Party   425    13,954 
           
Net Cash Flows from Financing Activities   425    13,954 
           
           
           
Net Change in Cash:   
—  
    
—  
 
           
Beginning Cash:  $
—  
   $
—  
 
           
Ending Cash:  $
—  
   $
—  
 
           
Supplemental Disclosures of Cash Flow Information:          
Cash paid for interest  $
—  
   $
—  
 
Cash paid for tax  $
—  
   $
—  
 

 

The accompanying notes are an integral part of these condensed unaudited financial statements.

  

 

 

 

4 

 

 

SAXON CAPITAL GROUP, INC.

NOTES TO CONDENSED UNAUDITED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND 2023

 

NOTE 1. NATURE OF OPERATIONS

 

Nature of Business

 

Saxon Capital Group Inc., formerly Atlas Technology Group Inc., is a SEC reporting shell company. There is no established public trading market for our shares which are quoted on the OTC Markets platform and are eligible for Unsolicited Quotes Only. We believe this is due to there being no broker dealers willing to quote our stock. We intend to seek approval for our shares of common stock to be traded on the Pink Sheets again. Once relisted on the Pink Sheets, we will then seek to merge with an entity with experienced management and opportunities for growth in return for shares of our common stock to create value for our shareholders. There is no guarantee that we will be successful in becoming relisted on the Pink Sheets and no potential merger candidate has been identified at this time.

 

Saxon Capital Group Inc. (“the Company,” “We," "Us," or “Our’) was incorporated under the laws of State of Delaware as on July 12, 2022.

 

Atlas Technology Group, Inc., a Florida corporation, merged into Saxon Capital Group, Inc effective from August 30, 2022. Now the surviving entity is Saxon Capital Group, Inc.

 

Effective May 29, 2021, we entered into an agreement with Corporate Excellence Consulting Inc. (“CECI”), our then controlling shareholder, and Mr. David Cutler (“Mr. Cutler”) (“the Agreement”) under which:

 

 

 

-

CECI surrendered, and we cancelled, the single outstanding share of Series A Preferred Stock. The single outstanding share of Series A Preferred Stock carried super preferred voting rights enabling the holder to vote the equivalent of 61% of all voteable preferred and common shares issued and outstanding,

 

  -

We issued a new share of Series A Preferred Stock, carrying the same super preferred voting rights described above, to Mr. Cutler. As a consequence of this issuance, Mr. Cutler became our new controlling shareholder,

 

  -

Mr. Cutler was appointed as a director of ours and as our Chief Financial Officer,

 

  -

Mr. Cutler paid $5,000 to CECI on our behalf as a partial repayment of the outstanding fees due by us to CECI,

 

  -

Mr. Cutler undertook to pay a further $30,000 on our behalf as a full and final settlement of the outstanding fees due by us to CECI, such payment to be made on the approval by FINRA of a proposed name change and reverse stock split,

 

  - CECI agreed to accept the $35,000 to be paid to them by Mr. Cutler on our behalf in full and final settlement of the outstanding fees due by us to CECI.

 

The initial payment of $5,000 to CECI was made by Mr. Cutler as agreed.

 

There is no guarantee that it will be possible to complete the remaining terms of the Agreement.

 

Effective November 10, 2021, the Board of directors recommended, and the holder of a majority of the voting power of our outstanding common stock voted, to approve the following items:

 

-a reverse split of the common stock issued and outstanding on a one new share for one million (1,000,000) old shares basis as of November 10, 2021. Fractional shares will be rounded up to the next whole share. (This action requires an amendment to the Certificate of Incorporation and requires the approval of the Financial Industry Regulatory Authority (“FINRA”)), and

 

5 

-a forward split of the common stock issued and outstanding as of November 10, 2021. Subsequent to the 1/1,000,000 reverse split described above, each share of post reverse split adjusted issued and outstanding Common Stock shall be forward split on a one for one hundred (100) basis such that each post reverse split old share represents 100 new shares. Fractional shares will be rounded up to the next whole share.

 

Effective November 17, 2022 Board of Director approved the following actions to:

-Cancel all 24,999,999 shares of authorized unissued shares of Series B Preferred Stock.
-Increase the number of shares authorized Series A Preferred Stock from 1 to 1,000.
-Forward split each share of issued and outstanding Series A Preferred Stock as of record date November 25, 2022 in the ratio of 1:1,000, such that each old share represents 1,000 new shares.

 

-Convert 499 post-split shares of Series A Preferred Stock into 9,130,995,911 shares of our common stock leaving 501 shares of post-split Series A stock issued and outstanding.

 

History

 

Saxon Capital Inc. was incorporated in the state of Nevada in August 1996 under the name Pan World Corporation. In November 1999, the Company changed its name to Tribeworks, Inc. and redomiciled to the state of Delaware. In August 2007, the Company changed its name to Atlas Technology Group, Inc. In August 2015, the Company redomiciled to the State of Florida. In December 2015, the Company changed its name to Moxie Motion Pictures, Inc. In November 2018, the Company changed its name back to Atlas Technology Group, Inc. On August 30, 2022, Atlas Technology Group, Inc. merged into Saxon Capital Group, Inc. and redomiciled from State of Florida to State of Delaware. Now the surviving corporation is Saxon Capital Group, Inc. On September 19, 2023, shareholder notice of corporate pursuant to Section 204 of the Delaware General Corporation Laws, on July 31, 2023, the company, as approved by the Board of Directors and the written consent of a majority of the shareholders, ratified a redomicile which was effective July 27, 2015.

 

Since its Inception in August 1996, the Company has at various times been involved in the following business activities: software sales, provision of information technology application support services, distribution of energy efficient lighting products and movie production and talent management.

 

By December 31, 2018, the Company had ceased all operations and had disposed of all its former operating subsidiaries.

 

Impact of the Ukrainian and Israeli Conflicts

 

We believe that the conflicts involving Ukraine and Israel do not have any direct impact on our operations, financial condition, or financial reporting.  We believe the conflicts will have only a general impact on our operations in the same manner as it is having a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from countries involved in the conflicts, supply chain challenges, and the international and US domestic inflation resulting from the conflict and government spending in relation to the conflicts. As our operations are related only to the small business loans in North America, we do not believe we will be targeted for cyber-attacks related to the conflicts. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate solely in the United States. We do not believe that the conflicts will have any impact on our internal control over financial reporting.  Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the conflicts.

 

 

6 

 

NOTE 2. GOING CONCERN

 

Our financial statements are prepared using accounting principles generally accepted in the United States of America (“GAAP”) applicable to a going concern, which contemplate the realization of assets and the liquidation of liabilities in the normal course of business. We have no ongoing business or income and for the three months period ended March 31, 2024 we incurred a loss of $15,680 and had an accumulated deficit of $31,161,535 as of March 31, 2024. These conditions raise substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of these uncertainties. Our ability to continue as a going concern is dependent upon our ability to raise additional debt or equity funding to meet our ongoing operating expenses and ultimately in merging with another entity with experienced management and profitable operations. No assurances can be given that we will be successful in achieving these objectives.

 

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

This summary of significant accounting policies is presented to assist in the understanding of the financial statements. These policies conform to GAAP and have been consistently applied. The Company has selected December 31 as its financial year end.

 

Interim Financial Statements

 

The accompanying unaudited interim condensed financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The accompanying condensed financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, changes in shareholders’ deficit and cash flows as of and for the three months ended March 31, 2024 and for the related periods presented, have been included. The results for the three months period ended March 31, 2024 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the financial statements and footnotes thereto for the years ended December 31, 2023 included in our Form 10-K filed on April 15, 2024.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents:

 

We maintain cash balances in a non-interest-bearing account that currently does not exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents. As of March 31, 2024 and December 31, 2023, our cash balances were $0.

 

Fair Value Measurements:

 

ASC Topic 820, Fair Value Measurements and Disclosures ("ASC 820"), provides a comprehensive framework for measuring fair value and expands disclosures which are required about fair value measurements. Specifically, ASC 820 sets forth a definition of fair value and establishes a hierarchy prioritizing the inputs to valuation techniques, giving the highest priority to quoted prices in active markets for identical assets and liabilities and the lowest priority to unobservable value inputs. ASC 820 defines the hierarchy as follows:

 

7 

 

Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange.

 

Level 2 – Pricing inputs are other than quoted prices in active markets but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts or priced with models using highly observable inputs.

 

Level 3 – Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value of financial transmission rights.

 

Our financial instruments consist of our accounts payable and accruals, accruals - related parties and note payable – related party. The carrying amount of our accounts payable and accruals, accruals - related parties and note payable – related party approximates their fair values because of the short-term maturities of these instruments.

 

Related Party Transactions:

 

A related party is generally defined as (i) any person that holds 10% or more of our membership interests including such person's immediate families, (ii) our management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with us, or (iv) any person who is or was (since the beginning of the last fiscal year, even if such person does not presently serve in that role) an executive officer, director or nominee for director of the Company, or (v) anyone who can significantly influence our financial and operating decisions. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. See Notes 5 and 6 below for details of related party transactions in the period presented.

 

Leases:

 

We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the balance sheet.

 

ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. We generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and exclude lease incentives. Lease expense for lease payment is recognized on a straight-line basis over lease term.

 

The Company was not party to any lease transaction for the three months ended March 31, 2024 and 2023.

 

Income Taxes:

 

The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carry-forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. We record a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

Uncertain Tax Positions:

 

We evaluate tax positions in a two-step process. We first determine whether it is more likely than not that a tax position will be sustained upon examination, based on the technical merits of the position. If a tax position meets the more-

8 

likely-than-not recognition threshold, it is then measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. We classify gross interest and penalties and unrecognized tax benefits that are not expected to result in payment or receipt of cash within one year as long-term liabilities in the financial statements.

 

Revenue Recognition:

 

Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

Step 1: Identify the contract(s) with customers.

Step 2: Identify the performance obligations in the contract.

Step 3: Determine the transaction price.

Step 4: Allocate the transaction price to performance obligations.

Step 5: Recognize revenue when the entity satisfies a performance obligation.

 

As the Company had no business operations during the three months period ended March 31, 2024 and 2023, we have not identified specific planned revenue streams.

 

During the three-month periods ended March 31, 2024 and 2023, we did not recognize any revenue.

 

Advertising Costs:

 

We expense advertising costs when advertisements occur. No advertising costs were incurred during the three-month periods ended March 31, 2024 or 2023.

 

Stock-Based Compensation:

 

The cost of equity instruments issued to employees and non-employees in return for goods and services is measured by the grant date fair value of the equity instruments issued in accordance with ASC 718, Compensation – Stock Compensation. The related expense is recognized as services are rendered or vesting periods elapse.

 

Net Loss per Share Calculation:

 

Basic earnings (loss) per common share ("EPS") is computed by dividing net income (loss) available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average shares outstanding, assuming all dilutive potential common shares were issued. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive.

 

Recently Accounting Pronouncements:

 

We have reviewed all the recently issued, but not yet effective, accounting pronouncements and do not believe any of these pronouncements will have a material impact on our financial statements.

 

NOTE 4. ACCOUNTS PAYABLE AND ACCRUALS

 

As of March 31, 2024 and December 31, 2023, the balance of accounts payable and accruals totaled $1,855 and $1,600, respectively. The balance owed as of March 31, 2024 and December 31, 2023 was principally due to the Company’s share transfer agent.

 

 

 

9 

NOTE 5. ACCRUALS - RELATED PARTIES

 

As of March 31, 2024 and December 31, 2023, the balance of accruals- related parties totaled $249,000 and $234,000 respectively.

 

These accruals relate to consulting fees due to our current controlling shareholder, director and chief financial officer ($170,000 and $155,000, respectively) and our former controlling shareholder ($79,000 and $79,000, respectively).

 

NOTE 6. NOTE PAYABLE – RELATED PARTY

 

As of March 31, 2024 and December 31, 2023, the balance of note payable – related party totaled $104,931 and $104,506, respectively.

 

During the three months period ended March 31, 2024, our controlling shareholder, director and chief financial officer, advanced to us $425 (2023 - $13,954), by way of a promissory note to finance our working capital requirements.

 

The promissory note is unsecured, due on demand and interest free.

 

NOTE 7. COMMITMENTS & CONTINGENCIES

 

Legal Proceedings

 

We were not subject to any legal proceedings during the three-month periods ended March 31, 2024 or 2023, and, to the best of our knowledge, no legal proceedings are pending or threatened.

 

Contractual Obligations

 

We are not party to any contractual obligations at this time.

 

NOTE 8. SHAREHOLDERS’ DEFICIT

 

Preferred Stock

 

We are authorized to issue 25,000,000 shares of preferred stock with a par value of $0.00001, with such relative rights, preferences and designations as may be determined by our Board of Directors in its sole discretion upon the issuance of any shares of Preferred Stock.

 

1 share of Series A Preferred Stock and 24,999,999 shares of Series B Preferred Stock were designated effective July 27, 2015.

 

Effective November 17, 2022 Board of Director approved the following actions to:

-Cancel all 24,999,999 shares of authorized but unissued shares of Series B Preferred Stock.
-Increase the number of shares authorized Series A Preferred Stock from 1 to 1,000.

 

As on March 31, 2024, there are 24,999,000 shares of preferred stock available for designation.

 

Series A Preferred Stock

 

As of March 31, 2024, we were authorized to issue 1,000 shares of Series A Preferred Stock with a par value of $0.00001.

 

501 share of Series A Preferred Stock was issued and outstanding as of March 31, 2024 and December 31, 2023.

 

10 

The share of Series A Preferred Stock carried super majority voting rights such that it can vote the equivalent of 61% of all votable preferred and common stock at all times.

 

The share of Series A Preferred Stock was convertible into 1,000 shares of common stock at the option of the Holder.

 

As described above, effective May 29, 2021, the 1 existing issued share of Series A Preferred Stock was returned to us by our former controlling shareholder and cancelled by us.

 

Further on May 29, 2021, we issued a new share of Series A Preferred Stock, valued by an independent, third party valuation company at $39,900, as compensation to our new controlling shareholder, director and Chief Financial Officer.

 

However, effective November 25, 2022, the single share of Series A Preferred Stock issued and outstanding was forward split in the ratio of 1:1,000, such that the single outstanding old share was replaced with 1,000 new shares.

 

The single share of Series A Preferred Stock originally carried super majority voting rights such that it could vote the equivalent of 61% of all votable preferred and common stock at all times.

 

Subsequently the super majority voting power of the single share of Series A Preferred Stock was increased from 61% to 68%.

 

Following the 1: 1,000 forward split effective November 25, 2022, each one of the 1,000 post forward split shares of Series A Preferred Stock is now convertible into 18,298,589 shares of common stock with total voting rights equal to 76% ownership of the common stock of the Company at the option of the Holder.

 

Effective November 25, 2022, 499 shares of Series A Preferred Stock was converted into 9,130,995,911 shares of common stock and the remaining 501 shares are issued and outstanding as on March 31, 2024.

 

As of March 31, 2024 and December 31, 2023, 501 shares of Series A Preferred Stock were issued and outstanding respectively.

 

Common Stock

 

As of March 31, 2024, we were authorized to issue 15,000,000,000 shares of common stock with a par value of $0.00001.

 

No shares of common stock were issued during the three months ended March 31, 2024 or 2023.


Effective November 10, 2021, the Company’s controlling shareholder and the Board approved a 1 for 1,000,000 reverse share split, followed by a 100 for 1 forward share split. This change in the number of common shares issued and outstanding is pending FINRA approval.

 

Effective November 25, 2022, 499 Series A Preferred Stock was converted into 9,130,995,911 shares of common stock.

 

As of March 31, 2024 and December 31, 2023, 14,981,701,785 shares of common stock were issued and outstanding.

 

Warrants

 

No warrants were issued or outstanding during the three-month periods ended March 31, 2024 and 2023.

 

Stock Options

 

We currently have no stock option plan.

 

No stock options were issued or outstanding during the three-month periods ended March 31, 2024 and 2023.

11 

 

NOTE 9. SUBSEQUENT EVENTS

 

The Company evaluated subsequent events after March 31, 2024, in accordance with FASB ASC 855 Subsequent Events, through the date of the issuance of these financial statements and has determined there have been no subsequent events for which disclosure is required.

 

12 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Forward-Looking Statements

 

Certain statements made in this quarterly report on Form 10-Q are “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995) in regard to the plans and objectives of management for future operations. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the registrant to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking statements included herein are based on current expectations that involve numerous risks and uncertainties. The Company’s plans and objectives are based, in part, on assumptions involving the continued expansion of business. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond the control of the Company. Although the Company believes its assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance the forward-looking statements included in this quarterly report will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by the registrant or any other person that the objectives and plans of the registrant will be achieved. 

 

Substantial risks exist with respect to an investment in the Company. These risks include but are not limited to, those factors discussed in our Annual Report on Form 10-K for the fiscal years ended December 31, 2023, filed with the Securities and Exchange Commission (“Commission”) on April 15, 2024. More broadly, these factors include, but are not limited to: 

  We have incurred significant losses and expect to incur future losses;

 

  Our current financial condition and immediate need for capital;

 

 

Potential significant dilution resulting from the issuance of new securities for any funding, debt conversion

or any business combination; and

 

  We are a “penny stock” company.

 

OVERVIEW

 

Saxon Capital Group, Inc., formerly Atlas Technology Group, Inc., a Delaware corporation, (“the Company”, “We", "Us" or “Our’) is a SEC reporting shell company. There is no established public trading market for our shares which are quoted on the OTC Markets platform and are eligible for Unsolicited Quotes Only. We believe this is due to there being no broker dealers willing to quote our stock. We intend to seek approval for our shares of common stock to be traded on the Pink Sheets again. Once relisted on the Pink Sheets, we will then seek to merge with an entity with experienced management and opportunities for growth in return for shares of our common stock to create value for our shareholders. There is no guarantee that we will be successful in becoming relisted on the Pink Sheets and no potential merger candidate has been identified at this time.

 

Saxon Capital Group Inc. (“the Company,” “We," "Us," or “Our’) was incorporated under the laws of State of Delaware as on July 12, 2022.

 

Atlas Technology Group, Inc., a Florida corporation, merged into Saxon Capital Group, Inc effective from August 30, 2022. Now the surviving entity is Saxon Capital Group, Inc.

  

PLAN OF OPERATION

 

Our plan of operation is to obtain debt or equity finance to meet our ongoing operating expenses and attempt to relist our shares of common stock on the Pink Sheets and then merge with another entity with experienced management and opportunities for growth in return for shares of our common stock to create value for our shareholders. There can be no assurance that any of the events can be successfully completed, that our shares of common stock will be relisted on the Pink Sheets, any such business will be identified or that any stockholder will realize any return on their shares after such a transaction has been completed. In particular, there is no assurance that any such business will be located

13 

or that any stockholder will realize any return on their shares after such a transaction. Any merger or acquisition completed by us can be expected to have a significant dilutive effect on the percentage of shares held by our current stockholders.

 

As of March 31, 2024, we had no cash on hand and committed resources of debt or equity to fund these losses. We will be reliant, potentially, on advances from our principal shareholders or our directors and officers. There can be no guarantee that we will be able to obtain sufficient funding these sources.

 

Our principal shareholder has indicated his intention to provide such funds as may be required for the Company to become, and remain, a fully reporting public company while seeking to create value for shareholders by merging with another entity with experienced management and opportunities for growth in return for shares of its common stock. Such intentions do not represent a binding commitment by the principal shareholder and there is no guarantee that our two principal shareholders will be able to provide the funding necessary to achieve this objective.

 

We currently believe that our principal shareholder will be able to provide us with the funding necessary to effect our business plan to merge with another entity. However, while our principal shareholder has indicated his intention to provide us with sufficient funding to achieve this objective, there is no guarantee that he will be able to provide funding necessary to enable us to merge with another entity.

 

If we are unable to obtain the necessary funding from our principal shareholder, we anticipate facing major challenges in raising the necessary funding to effect our business plan to merge with another entity. Raising debt or equity funding for small publicly quoted, penny stock, shell companies is always extremely challenging.

 

We may face a number of obstacles in our attempt to raise funding to achieve our objective of merging with a yet to be identified company or group. One of those is Rule 419, under the Securities Act of 1933.

 

Rule 419 defines a "blank check company" as a company that: i. Is a development stage company that has no specific business plan or purpose or has indicated that its business plan is to engage in a merger or acquisition with an unidentified company or companies, or other entity or person; and ii. Is issuing "penny stock," as defined in Rule 3a51-1 under the Securities Exchange Act of 1934.

 

We are a “blank check company” and therefore, in order to raise public or private funds, we must comply with the requirements of Rule 419 which includes restrictive escrow and other provisions. These provisions will make it difficult, if not impossible, for us to raise funds for the company.

 

Therefore, because of these difficulties in raising funding in penny stock or shell companies, if our principal shareholder is unable to provide us with the funding required to merge with another entity, it is very likely that we will be unable to implement our business plan to merge with another entity to create value for all of our shareholders”.

 

We believe we are an insignificant participant among the firms which engage in the acquisition of business opportunities. There are many established venture capital and financial concerns that have significantly greater financial and personnel resources and technical expertise than we have. In view of our limited financial resources and limited management availability, we will continue to be at a significant competitive disadvantage compared to our competitors.

 

We intend to seek, investigate and, if such investigation warrants, acquire an interest in business opportunities presented to us by persons or firms which desire to seek the advantages of an issuer who has complied with the Securities Act of 1934 (the “1934 Act”). We will not restrict our search to any specific business, industry or geographical location, and we may participate in business ventures of virtually any nature. This discussion of our proposed business is purposefully general and is not meant to be restrictive of our virtually unlimited discretion to search for and enter into potential business opportunities. We anticipate that we may be able to participate in only one potential business venture because of our lack of financial resources.

 

We may seek a business opportunity with entities which have recently commenced operations, or that desire to utilize the public marketplace in order to raise additional capital in order to expand into new products or markets, to develop

14 

a new product or service, or for other corporate purposes. We may acquire assets and establish wholly owned subsidiaries in various businesses or acquire existing businesses as subsidiaries.

 

We expect that the selection of a business opportunity will be complex and risky. Due to general economic conditions, rapid technological advances being made in some industries and shortages of available capital, we believe that there are numerous firms seeking the benefits of an issuer who has complied with the 1934 Act. Such benefits may include facilitating or improving the terms on which additional equity financing may be sought, providing liquidity for incentive stock options or similar benefits to key employees, providing liquidity (subject to restrictions of applicable statutes) for all stockholders and other factors. Potentially, available business opportunities may occur in many different industries and at various stages of development, all of which will make the task of comparative investigation and analysis of such business opportunities extremely difficult and complex. We have, and will continue to have, essentially no assets to provide the owners of business opportunities. However, we will be able to offer owners of acquisition candidates the opportunity to acquire a controlling ownership interest in an issuer who has complied with the 1934 Act without incurring the cost and time required to conduct an initial public offering.

 

The analysis of new business opportunities will be undertaken by, or under the supervision of, our sole director. We intend to concentrate on identifying preliminary prospective business opportunities which may be brought to our attention through present associations of our director, professional advisors or by our stockholders. In analyzing prospective business opportunities, we will consider such matters as (i) available technical, financial and managerial resources; (ii) working capital and other financial requirements; (iii) history of operations, if any, and prospects for the future; (iv) nature of present and expected competition; (v) quality, experience and depth of management services; (vi) potential for further research, development or exploration; (vii) specific risk factors not now foreseeable but that may be anticipated to impact the proposed activities of the company; (viii) potential for growth or expansion; (ix) potential for profit; (x) public recognition and acceptance of products, services or trades; (xi) name identification; and (xii) other factors that we consider relevant. As part of our investigation of the business opportunity, we expect to meet personally with management and key personnel. To the extent possible, we intend to utilize written reports and personal investigation to evaluate the above factors.

 

We will not acquire or merge with any company for which audited financial statements cannot be obtained within a reasonable period of time after closing of the proposed transaction.

 

RESULTS OF OPERATIONS

 

Our plan of operation is to obtain debt or equity finance to meet our ongoing operating expenses and attempt to relist our shares of common stock on the Pink Sheets and then merge with another entity with experienced management and opportunities for growth in return for shares of our common stock to create value for our shareholders. There can be no assurance that any of the events can be successfully completed, that our shares of common stock will be relisted on the Pink Sheets, any such business will be identified or that any stockholder will realize any return on their shares after such a transaction has been completed. In particular, there is no assurance that any such business will be located or that any stockholder will realize any return on their shares after such a transaction. Any merger or acquisition completed by us can be expected to have a significant dilutive effect on the percentage of shares held by our current stockholders.

 

THREE MONTHS ENDED MARCH 31, 2024 COMPARED TO THE THREE MONTHS ENDED MARCH 31, 2023

 

Revenue

 

We recognized no revenue during the three-month periods ended March 31, 2024 or 2023 as we had no revenue generating activities during these periods.

 

General and Administrative Expenses

 

During the three-month period ended March 31, 2024, we incurred general and administrative expenses of $15,680, comprising director’s fees of $15,000, accounting fees of $425, share transfer agent fees of $225 and EDGAR filing fees of $30.

15 

 

By comparison, during the three-months period ended March 31, 2023, we incurred general and administrative expenses of $27,279, comprising directors’ fees of $20,000, auditing fees of $5,000, FINRA and Edgar filing fees of $1,235 and $1,044 in other expenses.

 

Operating loss

 

During the three-month periods ended March 31, 2024 and 2023, we incurred operating losses of $15,680 and $27,279, respectively, due to the factors described above.

 

Other income expense

 

During the three-month periods ended March 31, 2024 and 2023, we recognized no other income (expense).

 

Loss before Income Tax

 

During the three-month periods ended March 31, 2024 and 2023, we recognized losses before income taxes of $15,680 and $27,279, respectively, due to the factors discussed above.

 

Provision for Income Tax

 

No provision for income taxes was recorded during the three-month periods ended March 31, 2024 and 2023 as we incurred taxable losses in both periods.

 

Net Loss

 

During the three-month periods ended March 31, 2024 and 2023, we recognized net losses of $15,680 and $27,279, respectively, due to the factors discussed above.

 

CASH FLOW

 

As of March 31, 2024, we did not have any cash or cash equivalents, no assets, no revenue generating activities or other source of income and we had outstanding liabilities of $355,786 and a shareholders’ deficit of $355,786.

 

By comparison, as of December 31, 2023, we did not have any cash or cash equivalents, no assets, no revenue generating activities or other source of income and we had outstanding liabilities of $340,106 and a shareholders’ deficit of $340,106.


Consequently, we are now dependent on raising additional equity and/or debt to meet our ongoing operating expenses. There is no assurance that we will be able to raise the necessary equity and/or debt that we will need to fund our ongoing operating expenses.

 

It is our current intention is to obtain debt or equity finance to meet our ongoing operating expenses and attempt to relist our shares of common stock on the Pink Sheets and then merge with another entity with experienced management and opportunities for growth in return for shares of our common stock to create value for our shareholders. There can be no assurance that any of the events can be successfully completed, that our shares of common stock will be relisted on the Pink Sheets, any such business will be identified or that any stockholder will realize any return on their shares after such a transaction has been completed. In particular, there is no assurance that any such business will be located or that any stockholder will realize any return on their shares after such a transaction. Any merger or acquisition completed by us can be expected to have a significant dilutive effect on the percentage of shares held by our current stockholders.

 

Future losses are likely to occur as, until we are able to merge with another entity with experienced management and opportunities for growth in return for shares of our common stock to create value for our shareholders, we have no sources of income to meet our operating expenses. As a result of these, among other factors, we received from our registered independent public accountants in their report for the financial statements for the years ended December

16 

31, 2023 and 2022, an explanatory paragraph stating that there is substantial doubt about our ability to continue as a going concern.

 

The following is a summary of the Company’s cash flows provided by (used in) operating, investing, and financing activities for the three-month periods ended March 31, 2024 and 2023:   

 

   For the three months ended
March 31,
2024
  For the three months ended March 31,
2023
Net Cash Used in Operating Activities  $(425)  $(13,954)
Net Cash Used in Investing Activities   —      —   
Net Cash Provided by Financing Activities   425    13,954 
Net Change in Cash  $—     $—   

 

Operating Activities

 

During the three-month period ended March 31, 2024, we recognized a net loss $15,680 which was reduced for cash flow purposes by a $255 increase in accounts payable and accruals and a $15,000 increase in accruals– related parties resulting in net cash of $425 being used in operating activities.

 

By comparison, during the three-month period ended March 31, 2023, we recognized a net loss $27,279 which was reduced for cash flow purposes by a $1,675 decrease in accounts payable and accruals and a $15,000 increase in accrued liabilities – related parties resulting in a net $13,954 cash being used in operating activities.

 

Investing Activities

 

We did not engage in any investing activities during the three-month periods ended March 31, 2024 and 2023.

 

Financing Activities

 

During the three-month period ended March 31, 2024, we received $425 by way of loan from our chief financial officer, director and controlling shareholder resulting in a total of $425 being generated from financing operations.

 

By comparison, during the three-months period ended March 31, 2023, we received $13,954 by way of loan from our chief financial officer, director and controlling shareholder resulting in a total of $13,954 generated from financing operations.

 

We are dependent upon the receipt of capital investment or other financing to fund our ongoing operations and to execute our business plan to merge with another entity with experienced management and opportunities for growth in return for shares of our common stock to create value for our shareholders. In addition, we are dependent upon our controlling shareholder to provide continued funding and capital resources. If continued funding and capital resources are unavailable at reasonable terms, we may not be able to implement our plan of operations.

 

CRITICAL ACCOUNTING POLICIES

 

All companies are required to include a discussion of critical accounting policies and estimates used in the preparation of their financial statements. On an on-going basis, we evaluate our critical accounting policies and estimates. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form our basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

17 

Our significant accounting policies are described in Note 3 of our Condensed Unaudited Financial Statements above. These policies were selected because they represent the more significant accounting policies and methods that are broadly applied in the preparation of our financial statements. 

 

Inflation

 

To date inflation has not been a major factor in our proposed business plan.  However, there are significant inflationary pressures in the larger economy. The impact of inflation is being reflected in higher wages, increased pricing of equipment and products and generally higher prices across all sectors of the economy.  We plan on carefully evaluating the impact of inflation and price increase pressures on our proposed business plan.

 

Off-Balance Sheet Arrangements

 

Per SEC regulations, we are required to disclose our off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, such as changes in financial condition, revenues, expenses, results of operations, liquidity, capital expenditures, or capital resources that are material to investors. As of March 31, 2024 and December 31, 2023, we had no off-balance sheet arrangements.

 

Share-based Compensation

 

The cost of equity instruments issued to non-employees in return for goods and services is measured by the fair value of the equity instruments issued in accordance with ASC 718, “Compensation - Stock Compensation.” Measurement date for non-employees is the grant date of the stock-based compensation. The cost of employee services received in exchange for equity instruments is based on the grant date fair value of the equity instruments issued.

 

Recently Issued Accounting Pronouncements

 

We have reviewed all the recently issued, but not yet effective, accounting pronouncements and do not believe any of these pronouncements will have a material impact on our financial statements.

 

Contractual Obligations

 

None.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Our management conducted an evaluation, with the participation of our Chief Executive Officer, who is our principal executive officer, and our Chief Financial Officer, who is our principal financial and accounting officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Form 10-Q. Based on that evaluation, we concluded that because of the material weakness and significant deficiencies in our internal control over financial reporting described below, our disclosure controls and procedures were not effective as of March 31, 2024.

 

 

 

18 

 

Management’s Annual Report on Internal Control over Financial Reporting

 

Management is responsible for the preparation of our financial statements and related information. Management uses its best judgment to ensure that the financial statements present accurately, in material respects, our financial position and results of operations in fairness and conformity with generally accepted accounting principles.

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in the Exchange Act. These internal controls are designed to provide reasonable assurance that the reported financial information is presented fairly, that disclosures are adequate, and that the assumptions and opinions in the preparation of financial statements are reasonable. There are inherent limitations in the effectiveness of any system of internal controls, including the possibility of human error and overriding of controls. Consequently, an ineffective internal control system can only provide reasonable, not absolute, assurance with respect to reporting financial information.

 

Our internal control over financial reporting includes policies and procedures that: (i) pertain to maintaining records that, in reasonable detail, accurately and fairly reflect our transactions; (ii) provide reasonable assurance that transactions are recorded as necessary for preparation of our financial statements in accordance with generally accepted accounting principles and that the receipts and expenditures of company assets are made in accordance with our management’s and directors’ authorization; and (iii) provide reasonable assurance regarding the prevention or timely detection of unauthorized acquisition, use, or disposition of assets that could have a material effect on our financial statements.

 

We conducted an evaluation of the effectiveness of our internal control over financial reporting, based on the framework in “Internal Control Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) and published in 2013, and subsequent guidance prepared by COSO specifically for smaller public companies. Based on that evaluation, management concluded that our internal control over financial reporting was not effective as of March 31, 2024 for the reasons discussed below.

 

A significant deficiency is a deficiency, or combination of deficiencies in internal control over financial reporting, that adversely affects the entity’s ability to initiate, authorize, record, process, or report financial data reliably in accordance with generally accepted accounting principles such that there is more than a remote likelihood that a misstatement of the entity’s financial statements that is more than inconsequential will not be prevented or detected by the entity’s internal control. A material weakness is a deficiency or a combination of deficiencies in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the annual or interim consolidated financial statements will not be prevented or detected on a timely basis. Management identified the following material weakness and significant deficiencies in its assessment of the effectiveness of internal control over financial reporting as of March 31, 2024:

  Lack of a functioning audit committee and lack of a majority of outside directors on our board of directors, resulting in ineffective oversight in the establishment and monitoring of required internal controls and procedures;
  Inadequate segregation of duties consistent with control objectives;
  Insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of US GAAP and SEC disclosure requirements; and
  Ineffective controls over period end financial disclosure and reporting processes.

 

There are no assurances that the material weaknesses and significant deficiencies in our disclosure controls and procedures and internal control over financial reporting will not result in errors in our financial statements, which could lead to a restatement of those financial statements. Our management does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and maintained, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must account for resource constraints. In addition, the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, can and will be detected.

19 

 

This Form 10-Q does not include an attestation report from our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the Commission that permit us to provide only management’s report in this Form 10-Q.

 

Changes in Internal Controls over Financial Reporting

 

There have been no changes in our internal control over financial reporting during the three-month period ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II

 

OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

There are presently no material pending legal proceedings to which the Company, any executive officer, any owner of record or beneficially of more than five percent of any class of voting securities is a party or as to which any of its property is subject, and no such proceedings are known to the Company to be threatened or contemplated against it.

 

Item 1A. Risk Factors.

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item.

 

Item 2. Unregistered Sale of Equity Securities and Use of Proceeds.

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable to our Company.

 

Item 5. Other Information.

 

None.

 

20 

 

Item 6. Exhibits.

 

31.1 Certification of Chief Executive Officer Pursuant to Rule 13a–14(a) or 15d-14(a) of the Securities Exchange Act of 1934
31.2 Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934
32.1 Certification of Chief Executive Officer under Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2 Certification of Chief Financial Officer under Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH Inline XBRL Taxonomy Extension Schema Document
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (formatted as an Inline XBRL document and included in Exhibit 101)

 

21 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: May 20, 2024 SAXON CAPITAL GROUP, INC.
   
  s/ Redgie Green
  Redgie Green
  Director and CEO
  (Chief Executive Officer and Principal Executive Officer)
   
   
  /s/ David Cutler
  David Cutler
  Director and CFO
  (Chief Financial Officer and Principal Accounting Officer)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

22 

 

Saxon Capital Group, Inc./DE 0.00 0.00 14981701785 14981701785 false --12-31 Q1 0001093636 0001093636 2024-01-01 2024-03-31 0001093636 2024-05-15 0001093636 2024-03-31 0001093636 2023-12-31 0001093636 us-gaap:RelatedPartyMember 2024-03-31 0001093636 us-gaap:RelatedPartyMember 2023-12-31 0001093636 us-gaap:SeriesAPreferredStockMember 2024-03-31 0001093636 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001093636 2023-01-01 2023-03-31 0001093636 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001093636 us-gaap:CommonStockMember 2023-12-31 0001093636 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001093636 us-gaap:RetainedEarningsMember 2023-12-31 0001093636 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001093636 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001093636 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001093636 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001093636 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001093636 us-gaap:CommonStockMember 2024-03-31 0001093636 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001093636 us-gaap:RetainedEarningsMember 2024-03-31 0001093636 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001093636 us-gaap:CommonStockMember 2022-12-31 0001093636 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001093636 us-gaap:RetainedEarningsMember 2022-12-31 0001093636 2022-12-31 0001093636 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001093636 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001093636 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001093636 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001093636 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001093636 us-gaap:CommonStockMember 2023-03-31 0001093636 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001093636 us-gaap:RetainedEarningsMember 2023-03-31 0001093636 2023-03-31 0001093636 us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-03-31 0001093636 atyg:CorporateExcellenceConsultingIncMember 2024-01-01 2024-03-31 0001093636 atyg:CorporateExcellenceConsultingIncMember 2024-03-31 0001093636 atyg:CorporateExcellenceConsultingIncMember atyg:MrCutlerMember 2024-03-31 0001093636 srt:BoardOfDirectorsChairmanMember us-gaap:SeriesBPreferredStockMember 2022-11-17 0001093636 srt:MinimumMember srt:BoardOfDirectorsChairmanMember us-gaap:SeriesAPreferredStockMember 2022-11-17 0001093636 srt:MaximumMember srt:BoardOfDirectorsChairmanMember us-gaap:SeriesAPreferredStockMember 2022-11-17 0001093636 atyg:CurrentControllingShareholderDirectorAndChiefFinancialOfficerMember 2024-03-31 0001093636 atyg:FormerControllingShareholderMember 2024-03-31 0001093636 atyg:CurrentControllingShareholderDirectorAndChiefFinancialOfficerMember 2023-12-31 0001093636 atyg:FormerControllingShareholderMember 2023-12-31 0001093636 us-gaap:PreferredStockMember 2024-03-31 0001093636 us-gaap:SeriesAPreferredStockMember 2015-07-27 0001093636 us-gaap:SeriesBPreferredStockMember 2015-07-27 0001093636 us-gaap:SeriesBPreferredStockMember 2024-03-31 0001093636 us-gaap:SeriesBPreferredStockMember 2023-12-31 0001093636 us-gaap:SeriesAPreferredStockMember 2021-05-29 0001093636 srt:MinimumMember us-gaap:SeriesAPreferredStockMember 2022-11-01 2022-11-25 0001093636 srt:MaximumMember us-gaap:SeriesAPreferredStockMember 2022-11-01 2022-11-25 0001093636 us-gaap:SeriesAPreferredStockMember 2022-11-01 2022-11-25 0001093636 srt:MinimumMember us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-03-31 0001093636 srt:MaximumMember us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-03-31 0001093636 us-gaap:CommonStockMember 2024-03-31 0001093636 srt:MinimumMember 2021-11-01 2021-11-10 0001093636 srt:MaximumMember 2021-11-01 2021-11-10 0001093636 atyg:SeriesAPreferredStockOneMember 2022-11-25 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

EXHIBIT 31.1 

 

CERTIFICATION OF PERIODIC REPORT

 

I, Redgie Green, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Saxon Capital Group, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f)) for the registrant and have:

 

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s 4th quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 20, 2024

 

/s/ Redgie Green  
Redgie Green  
(Chief Executive Officer and Principal Executive Officer)  

 

EXHIBIT 31.2 

 

CERTIFICATION OF PERIODIC REPORT

 

I, David Cutler, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Saxon Capital Group, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f)) for the registrant and have:

 

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s 4th quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 20, 2024

 

/s/ David Cutler  
David Cutler  
(Chief Financial Officer and Principal Accounting Officer)  

 

EXHIBIT 32.1

 

CERTIFICATION OF DISCLOSURE PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Saxon Capital Group, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) I, Redgie Green, Chief Executive Officer and Principal Executive Officer of the Company, certify, pursuant to 18 USC Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: May 20, 2024

 

/s/ Redgie Green  
Redgie Green  
(Chief Executive Officer and Principal Executive Officer)  

 

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

EXHIBIT 32.2

 

CERTIFICATION OF DISCLOSURE PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Saxon Capital Group, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) I, David Cutler, Chief Financial Officer and Principal Accounting Officer of the Company, certify, pursuant to 18 USC Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: May 20, 2024

 

/s/ David Cutler  
David Cutler  
(Chief Financial Officer and Principal Accounting Officer)  

 

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

 

v3.24.1.1.u2
Cover - shares
3 Months Ended
Mar. 31, 2024
May 15, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Amendment Flag false  
Document Period End Date Mar. 31, 2024  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Entity Information [Line Items]    
Entity Registrant Name Saxon Capital Group, Inc./DE  
Entity Central Index Key 0001093636  
Entity File Number 000-28675  
Entity Tax Identification Number 94-3370795  
Entity Incorporation, State or Country Code DE  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Shell Company true  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Contact Personnel [Line Items]    
Entity Address, Address Line One PO Box 147165  
Entity Address, City or Town Lakewood  
Entity Address, State or Province CO  
Entity Address, Postal Zip Code 80214  
Entity Phone Fax Numbers [Line Items]    
City Area Code 303  
Local Phone Number 323-4896  
Entity Listings [Line Items]    
Entity Common Stock, Shares Outstanding   14,981,701,785
v3.24.1.1.u2
Condensed Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and Cash Equivalents
Total Current Assets
Total Assets
Current Liabilities    
Accounts Payable 1,855 1,600
Total Current Liabilities 355,786 340,106
Total Liabilities 355,786 340,106
Commitments and Contingencies (Note 7)
Shareholders' Deficit    
Preferred stock, value
Common Stock, $0.00001 par value, 15,000,000,000 shares authorized, 14,981,701,785 shares issued and outstanding as of March 31, 2024 and December 31, 2023 149,817 149,817
Additional Paid In Capital 30,635,942 30,635,942
Accumulated Deficit (31,161,535) (31,145,855)
Total Shareholders’ Deficit (355,786) (340,106)
Total Liabilities and Shareholders' Deficit
Related Party    
Current Liabilities    
Accruals - Related Parties 249,000 234,000
Note Payable - Related Party 104,931 104,506
Series A Preferred Stock    
Shareholders' Deficit    
Preferred stock, value $ 19,990 $ 19,990
v3.24.1.1.u2
Condensed Balance Sheets (Parentheticals) - $ / shares
Mar. 31, 2024
Dec. 31, 2023
Preferred stock, par value (in Dollars per share) $ 0.00001 $ 0.00001
Preferred stock, shares authorized 24,999,000 24,999,000
Common stock, par value (in Dollars per share) $ 0.00001 $ 0.00001
Common stock, shares authorized 15,000,000,000 15,000,000,000
Common stock, shares issued 14,981,701,785 14,981,701,785
Common stock, shares outstanding 14,981,701,785 14,981,701,785
Series A Preferred Stock    
Preferred stock, par value (in Dollars per share) $ 0.00001 $ 0.00001
Preferred stock, shares authorized 1,000 1,000
Preferred stock, shares issued 501 501
Preferred stock, shares outstanding 501 501
v3.24.1.1.u2
Condensed Unaudited Statement of Operations - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
REVENUE
OPERATING EXPENSES:    
General and administrative expenses 15,680 27,279
Total Operating Expenses 15,680 27,279
OPERATING LOSS (15,680) (27,279)
OTHER INCOME (EXPENSE)
LOSS BEFORE TAXES (15,680) (27,279)
TAXES
NET LOSS $ (15,680) $ (27,279)
Net Loss per Common Shares Outstanding – Basic (in Dollars per share) $ 0 $ 0
Weighted Average Common Shares Outstanding – Basic (in Shares) 14,981,701,785 14,981,701,785
v3.24.1.1.u2
Condensed Unaudited Statement of Operations (Parentheticals) - $ / shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Net Loss per Common Shares Outstanding – Diluted $ 0.00 $ 0.00
Weighted Average Common Shares Outstanding – Diluted 14,981,701,785 14,981,701,785
v3.24.1.1.u2
Condensed Unaudited Statements of Changes in Shareholders’ Deficit - USD ($)
Preferred Shares
Series A
Common Shares
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 19,900 $ 149,817 $ 30,635,942 $ (31,053,631) $ (247,882)
Balance (in Shares) at Dec. 31, 2022 501 14,981,701,785      
Net loss for the period (27,279) (27,279)
Balance at Mar. 31, 2023 $ 19,900 $ 149,817 30,635,942 (31,080,910) (275,161)
Balance (in Shares) at Mar. 31, 2023 501 14,981,701,785      
Balance at Dec. 31, 2023 $ 19,990 $ 149,817 30,635,942 (31,145,855) (340,106)
Balance (in Shares) at Dec. 31, 2023 501 14,981,701,785      
Net loss for the period (15,680) (15,680)
Balance at Mar. 31, 2024 $ 19,990 $ 149,817 $ 30,635,942 $ (31,161,535) $ (355,786)
Balance (in Shares) at Mar. 31, 2024 501 14,981,701,785      
v3.24.1.1.u2
Condensed Unaudited Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows from Operating Activities:    
Net Loss $ (15,680) $ (27,279)
Changes in working capital items:    
Accounts Payable and Accruals 255 (1,675)
Accruals - Related Parties 15,000 15,000
Net Cash Flows Used in Operating Activities (425) (13,954)
Net Cash Flows from Investing Activities
Cash Flows from Financing Activities    
Note Payable - Related Party 425 13,954
Net Cash Flows from Financing Activities 425 13,954
Net Change in Cash
Beginning Cash
Ending Cash
Supplemental Disclosures of Cash Flow Information:    
Cash paid for interest
Cash paid for tax
v3.24.1.1.u2
Nature of Operations
3 Months Ended
Mar. 31, 2024
Nature of Operations [Abstract]  
NATURE OF OPERATIONS

NOTE 1. NATURE OF OPERATIONS

 

Nature of Business

 

Saxon Capital Group Inc., formerly Atlas Technology Group Inc., is a SEC reporting shell company. There is no established public trading market for our shares which are quoted on the OTC Markets platform and are eligible for Unsolicited Quotes Only. We believe this is due to there being no broker dealers willing to quote our stock. We intend to seek approval for our shares of common stock to be traded on the Pink Sheets again. Once relisted on the Pink Sheets, we will then seek to merge with an entity with experienced management and opportunities for growth in return for shares of our common stock to create value for our shareholders. There is no guarantee that we will be successful in becoming relisted on the Pink Sheets and no potential merger candidate has been identified at this time.

 

Saxon Capital Group Inc. (“the Company,” “We," "Us," or “Our’) was incorporated under the laws of State of Delaware as on July 12, 2022.

 

Atlas Technology Group, Inc., a Florida corporation, merged into Saxon Capital Group, Inc effective from August 30, 2022. Now the surviving entity is Saxon Capital Group, Inc.

 

Effective May 29, 2021, we entered into an agreement with Corporate Excellence Consulting Inc. (“CECI”), our then controlling shareholder, and Mr. David Cutler (“Mr. Cutler”) (“the Agreement”) under which:

 

 

 

-

CECI surrendered, and we cancelled, the single outstanding share of Series A Preferred Stock. The single outstanding share of Series A Preferred Stock carried super preferred voting rights enabling the holder to vote the equivalent of 61% of all voteable preferred and common shares issued and outstanding,

 

  -

We issued a new share of Series A Preferred Stock, carrying the same super preferred voting rights described above, to Mr. Cutler. As a consequence of this issuance, Mr. Cutler became our new controlling shareholder,

 

  -

Mr. Cutler was appointed as a director of ours and as our Chief Financial Officer,

 

  -

Mr. Cutler paid $5,000 to CECI on our behalf as a partial repayment of the outstanding fees due by us to CECI,

 

  -

Mr. Cutler undertook to pay a further $30,000 on our behalf as a full and final settlement of the outstanding fees due by us to CECI, such payment to be made on the approval by FINRA of a proposed name change and reverse stock split,

 

  - CECI agreed to accept the $35,000 to be paid to them by Mr. Cutler on our behalf in full and final settlement of the outstanding fees due by us to CECI.

 

The initial payment of $5,000 to CECI was made by Mr. Cutler as agreed.

 

There is no guarantee that it will be possible to complete the remaining terms of the Agreement.

 

Effective November 10, 2021, the Board of directors recommended, and the holder of a majority of the voting power of our outstanding common stock voted, to approve the following items:

 

-a reverse split of the common stock issued and outstanding on a one new share for one million (1,000,000) old shares basis as of November 10, 2021. Fractional shares will be rounded up to the next whole share. (This action requires an amendment to the Certificate of Incorporation and requires the approval of the Financial Industry Regulatory Authority (“FINRA”)), and

 

-a forward split of the common stock issued and outstanding as of November 10, 2021. Subsequent to the 1/1,000,000 reverse split described above, each share of post reverse split adjusted issued and outstanding Common Stock shall be forward split on a one for one hundred (100) basis such that each post reverse split old share represents 100 new shares. Fractional shares will be rounded up to the next whole share.

 

Effective November 17, 2022 Board of Director approved the following actions to:

-Cancel all 24,999,999 shares of authorized unissued shares of Series B Preferred Stock.
-Increase the number of shares authorized Series A Preferred Stock from 1 to 1,000.
-Forward split each share of issued and outstanding Series A Preferred Stock as of record date November 25, 2022 in the ratio of 1:1,000, such that each old share represents 1,000 new shares.

 

-Convert 499 post-split shares of Series A Preferred Stock into 9,130,995,911 shares of our common stock leaving 501 shares of post-split Series A stock issued and outstanding.

 

History

 

Saxon Capital Inc. was incorporated in the state of Nevada in August 1996 under the name Pan World Corporation. In November 1999, the Company changed its name to Tribeworks, Inc. and redomiciled to the state of Delaware. In August 2007, the Company changed its name to Atlas Technology Group, Inc. In August 2015, the Company redomiciled to the State of Florida. In December 2015, the Company changed its name to Moxie Motion Pictures, Inc. In November 2018, the Company changed its name back to Atlas Technology Group, Inc. On August 30, 2022, Atlas Technology Group, Inc. merged into Saxon Capital Group, Inc. and redomiciled from State of Florida to State of Delaware. Now the surviving corporation is Saxon Capital Group, Inc. On September 19, 2023, shareholder notice of corporate pursuant to Section 204 of the Delaware General Corporation Laws, on July 31, 2023, the company, as approved by the Board of Directors and the written consent of a majority of the shareholders, ratified a redomicile which was effective July 27, 2015.

 

Since its Inception in August 1996, the Company has at various times been involved in the following business activities: software sales, provision of information technology application support services, distribution of energy efficient lighting products and movie production and talent management.

 

By December 31, 2018, the Company had ceased all operations and had disposed of all its former operating subsidiaries.

 

Impact of the Ukrainian and Israeli Conflicts

 

We believe that the conflicts involving Ukraine and Israel do not have any direct impact on our operations, financial condition, or financial reporting.  We believe the conflicts will have only a general impact on our operations in the same manner as it is having a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from countries involved in the conflicts, supply chain challenges, and the international and US domestic inflation resulting from the conflict and government spending in relation to the conflicts. As our operations are related only to the small business loans in North America, we do not believe we will be targeted for cyber-attacks related to the conflicts. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate solely in the United States. We do not believe that the conflicts will have any impact on our internal control over financial reporting.  Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the conflicts.

v3.24.1.1.u2
Going Concern
3 Months Ended
Mar. 31, 2024
Going Concern [Abstract]  
GOING CONCERN

NOTE 2. GOING CONCERN

 

Our financial statements are prepared using accounting principles generally accepted in the United States of America (“GAAP”) applicable to a going concern, which contemplate the realization of assets and the liquidation of liabilities in the normal course of business. We have no ongoing business or income and for the three months period ended March 31, 2024 we incurred a loss of $15,680 and had an accumulated deficit of $31,161,535 as of March 31, 2024. These conditions raise substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of these uncertainties. Our ability to continue as a going concern is dependent upon our ability to raise additional debt or equity funding to meet our ongoing operating expenses and ultimately in merging with another entity with experienced management and profitable operations. No assurances can be given that we will be successful in achieving these objectives.

v3.24.1.1.u2
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2024
Summary of Significant Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

This summary of significant accounting policies is presented to assist in the understanding of the financial statements. These policies conform to GAAP and have been consistently applied. The Company has selected December 31 as its financial year end.

 

Interim Financial Statements

 

The accompanying unaudited interim condensed financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The accompanying condensed financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, changes in shareholders’ deficit and cash flows as of and for the three months ended March 31, 2024 and for the related periods presented, have been included. The results for the three months period ended March 31, 2024 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the financial statements and footnotes thereto for the years ended December 31, 2023 included in our Form 10-K filed on April 15, 2024.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents:

 

We maintain cash balances in a non-interest-bearing account that currently does not exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents. As of March 31, 2024 and December 31, 2023, our cash balances were $0.

 

Fair Value Measurements:

 

ASC Topic 820, Fair Value Measurements and Disclosures ("ASC 820"), provides a comprehensive framework for measuring fair value and expands disclosures which are required about fair value measurements. Specifically, ASC 820 sets forth a definition of fair value and establishes a hierarchy prioritizing the inputs to valuation techniques, giving the highest priority to quoted prices in active markets for identical assets and liabilities and the lowest priority to unobservable value inputs. ASC 820 defines the hierarchy as follows:

 

Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange.

 

Level 2 – Pricing inputs are other than quoted prices in active markets but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts or priced with models using highly observable inputs.

 

Level 3 – Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value of financial transmission rights.

 

Our financial instruments consist of our accounts payable and accruals, accruals - related parties and note payable – related party. The carrying amount of our accounts payable and accruals, accruals - related parties and note payable – related party approximates their fair values because of the short-term maturities of these instruments.

 

Related Party Transactions:

 

A related party is generally defined as (i) any person that holds 10% or more of our membership interests including such person's immediate families, (ii) our management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with us, or (iv) any person who is or was (since the beginning of the last fiscal year, even if such person does not presently serve in that role) an executive officer, director or nominee for director of the Company, or (v) anyone who can significantly influence our financial and operating decisions. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. See Notes 5 and 6 below for details of related party transactions in the period presented.

 

Leases:

 

We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the balance sheet.

 

ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. We generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and exclude lease incentives. Lease expense for lease payment is recognized on a straight-line basis over lease term.

 

The Company was not party to any lease transaction for the three months ended March 31, 2024 and 2023.

 

Income Taxes:

 

The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carry-forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. We record a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

Uncertain Tax Positions:

 

We evaluate tax positions in a two-step process. We first determine whether it is more likely than not that a tax position will be sustained upon examination, based on the technical merits of the position. If a tax position meets the more-

likely-than-not recognition threshold, it is then measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. We classify gross interest and penalties and unrecognized tax benefits that are not expected to result in payment or receipt of cash within one year as long-term liabilities in the financial statements.

 

Revenue Recognition:

 

Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

Step 1: Identify the contract(s) with customers.

Step 2: Identify the performance obligations in the contract.

Step 3: Determine the transaction price.

Step 4: Allocate the transaction price to performance obligations.

Step 5: Recognize revenue when the entity satisfies a performance obligation.

 

As the Company had no business operations during the three months period ended March 31, 2024 and 2023, we have not identified specific planned revenue streams.

 

During the three-month periods ended March 31, 2024 and 2023, we did not recognize any revenue.

 

Advertising Costs:

 

We expense advertising costs when advertisements occur. No advertising costs were incurred during the three-month periods ended March 31, 2024 or 2023.

 

Stock-Based Compensation:

 

The cost of equity instruments issued to employees and non-employees in return for goods and services is measured by the grant date fair value of the equity instruments issued in accordance with ASC 718, Compensation – Stock Compensation. The related expense is recognized as services are rendered or vesting periods elapse.

 

Net Loss per Share Calculation:

 

Basic earnings (loss) per common share ("EPS") is computed by dividing net income (loss) available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average shares outstanding, assuming all dilutive potential common shares were issued. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive.

 

Recently Accounting Pronouncements:

 

We have reviewed all the recently issued, but not yet effective, accounting pronouncements and do not believe any of these pronouncements will have a material impact on our financial statements.

v3.24.1.1.u2
Accounts Payable and Accruals
3 Months Ended
Mar. 31, 2024
Accounts Payable and Accruals [Abstract]  
ACCOUNTS PAYABLE AND ACCRUALS

NOTE 4. ACCOUNTS PAYABLE AND ACCRUALS

 

As of March 31, 2024 and December 31, 2023, the balance of accounts payable and accruals totaled $1,855 and $1,600, respectively. The balance owed as of March 31, 2024 and December 31, 2023 was principally due to the Company’s share transfer agent.

v3.24.1.1.u2
Accruals - Related Parties
3 Months Ended
Mar. 31, 2024
Accruals - Related Parties [Abstract]  
ACCRUALS - RELATED PARTIES

NOTE 5. ACCRUALS - RELATED PARTIES

 

As of March 31, 2024 and December 31, 2023, the balance of accruals- related parties totaled $249,000 and $234,000 respectively.

 

These accruals relate to consulting fees due to our current controlling shareholder, director and chief financial officer ($170,000 and $155,000, respectively) and our former controlling shareholder ($79,000 and $79,000, respectively).

v3.24.1.1.u2
Note Payable – Related Party
3 Months Ended
Mar. 31, 2024
Note Payable – Related Party [Abstract]  
NOTE PAYABLE – RELATED PARTY

NOTE 6. NOTE PAYABLE – RELATED PARTY

 

As of March 31, 2024 and December 31, 2023, the balance of note payable – related party totaled $104,931 and $104,506, respectively.

 

During the three months period ended March 31, 2024, our controlling shareholder, director and chief financial officer, advanced to us $425 (2023 - $13,954), by way of a promissory note to finance our working capital requirements.

 

The promissory note is unsecured, due on demand and interest free.

v3.24.1.1.u2
Commitments & Contingencies
3 Months Ended
Mar. 31, 2024
Commitments & Contingencies [Abstract]  
COMMITMENTS & CONTINGENCIES

NOTE 7. COMMITMENTS & CONTINGENCIES

 

Legal Proceedings

 

We were not subject to any legal proceedings during the three-month periods ended March 31, 2024 or 2023, and, to the best of our knowledge, no legal proceedings are pending or threatened.

 

Contractual Obligations

 

We are not party to any contractual obligations at this time.

v3.24.1.1.u2
Shareholders’ Deficit
3 Months Ended
Mar. 31, 2024
Shareholders’ Deficit [Abstract]  
SHAREHOLDERS’ DEFICIT

NOTE 8. SHAREHOLDERS’ DEFICIT

 

Preferred Stock

 

We are authorized to issue 25,000,000 shares of preferred stock with a par value of $0.00001, with such relative rights, preferences and designations as may be determined by our Board of Directors in its sole discretion upon the issuance of any shares of Preferred Stock.

 

1 share of Series A Preferred Stock and 24,999,999 shares of Series B Preferred Stock were designated effective July 27, 2015.

 

Effective November 17, 2022 Board of Director approved the following actions to:

-Cancel all 24,999,999 shares of authorized but unissued shares of Series B Preferred Stock.
-Increase the number of shares authorized Series A Preferred Stock from 1 to 1,000.

 

As on March 31, 2024, there are 24,999,000 shares of preferred stock available for designation.

 

Series A Preferred Stock

 

As of March 31, 2024, we were authorized to issue 1,000 shares of Series A Preferred Stock with a par value of $0.00001.

 

501 share of Series A Preferred Stock was issued and outstanding as of March 31, 2024 and December 31, 2023.

 

The share of Series A Preferred Stock carried super majority voting rights such that it can vote the equivalent of 61% of all votable preferred and common stock at all times.

 

The share of Series A Preferred Stock was convertible into 1,000 shares of common stock at the option of the Holder.

 

As described above, effective May 29, 2021, the 1 existing issued share of Series A Preferred Stock was returned to us by our former controlling shareholder and cancelled by us.

 

Further on May 29, 2021, we issued a new share of Series A Preferred Stock, valued by an independent, third party valuation company at $39,900, as compensation to our new controlling shareholder, director and Chief Financial Officer.

 

However, effective November 25, 2022, the single share of Series A Preferred Stock issued and outstanding was forward split in the ratio of 1:1,000, such that the single outstanding old share was replaced with 1,000 new shares.

 

The single share of Series A Preferred Stock originally carried super majority voting rights such that it could vote the equivalent of 61% of all votable preferred and common stock at all times.

 

Subsequently the super majority voting power of the single share of Series A Preferred Stock was increased from 61% to 68%.

 

Following the 1: 1,000 forward split effective November 25, 2022, each one of the 1,000 post forward split shares of Series A Preferred Stock is now convertible into 18,298,589 shares of common stock with total voting rights equal to 76% ownership of the common stock of the Company at the option of the Holder.

 

Effective November 25, 2022, 499 shares of Series A Preferred Stock was converted into 9,130,995,911 shares of common stock and the remaining 501 shares are issued and outstanding as on March 31, 2024.

 

As of March 31, 2024 and December 31, 2023, 501 shares of Series A Preferred Stock were issued and outstanding respectively.

 

Common Stock

 

As of March 31, 2024, we were authorized to issue 15,000,000,000 shares of common stock with a par value of $0.00001.

 

No shares of common stock were issued during the three months ended March 31, 2024 or 2023.


Effective November 10, 2021, the Company’s controlling shareholder and the Board approved a 1 for 1,000,000 reverse share split, followed by a 100 for 1 forward share split. This change in the number of common shares issued and outstanding is pending FINRA approval.

 

Effective November 25, 2022, 499 Series A Preferred Stock was converted into 9,130,995,911 shares of common stock.

 

As of March 31, 2024 and December 31, 2023, 14,981,701,785 shares of common stock were issued and outstanding.

 

Warrants

 

No warrants were issued or outstanding during the three-month periods ended March 31, 2024 and 2023.

 

Stock Options

 

We currently have no stock option plan.

 

No stock options were issued or outstanding during the three-month periods ended March 31, 2024 and 2023.

v3.24.1.1.u2
Subsequent Events
3 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 9. SUBSEQUENT EVENTS

 

The Company evaluated subsequent events after March 31, 2024, in accordance with FASB ASC 855 Subsequent Events, through the date of the issuance of these financial statements and has determined there have been no subsequent events for which disclosure is required.

v3.24.1.1.u2
Pay vs Performance Disclosure - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pay vs Performance Disclosure    
Net Income (Loss) $ (15,680) $ (27,279)
v3.24.1.1.u2
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.1.1.u2
Accounting Policies, by Policy (Policies)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

This summary of significant accounting policies is presented to assist in the understanding of the financial statements. These policies conform to GAAP and have been consistently applied. The Company has selected December 31 as its financial year end.

Interim Financial Statements

Interim Financial Statements

The accompanying unaudited interim condensed financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The accompanying condensed financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, changes in shareholders’ deficit and cash flows as of and for the three months ended March 31, 2024 and for the related periods presented, have been included. The results for the three months period ended March 31, 2024 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the financial statements and footnotes thereto for the years ended December 31, 2023 included in our Form 10-K filed on April 15, 2024.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents:

We maintain cash balances in a non-interest-bearing account that currently does not exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents. As of March 31, 2024 and December 31, 2023, our cash balances were $0.

Fair Value Measurements

Fair Value Measurements:

ASC Topic 820, Fair Value Measurements and Disclosures ("ASC 820"), provides a comprehensive framework for measuring fair value and expands disclosures which are required about fair value measurements. Specifically, ASC 820 sets forth a definition of fair value and establishes a hierarchy prioritizing the inputs to valuation techniques, giving the highest priority to quoted prices in active markets for identical assets and liabilities and the lowest priority to unobservable value inputs. ASC 820 defines the hierarchy as follows:

 

Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange.

Level 2 – Pricing inputs are other than quoted prices in active markets but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts or priced with models using highly observable inputs.

Level 3 – Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value of financial transmission rights.

Our financial instruments consist of our accounts payable and accruals, accruals - related parties and note payable – related party. The carrying amount of our accounts payable and accruals, accruals - related parties and note payable – related party approximates their fair values because of the short-term maturities of these instruments.

Related Party Transactions

Related Party Transactions:

A related party is generally defined as (i) any person that holds 10% or more of our membership interests including such person's immediate families, (ii) our management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with us, or (iv) any person who is or was (since the beginning of the last fiscal year, even if such person does not presently serve in that role) an executive officer, director or nominee for director of the Company, or (v) anyone who can significantly influence our financial and operating decisions. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. See Notes 5 and 6 below for details of related party transactions in the period presented.

Leases

Leases:

We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the balance sheet.

ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. We generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and exclude lease incentives. Lease expense for lease payment is recognized on a straight-line basis over lease term.

The Company was not party to any lease transaction for the three months ended March 31, 2024 and 2023.

Income Taxes

Income Taxes:

The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carry-forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. We record a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

Uncertain Tax Positions

Uncertain Tax Positions:

We evaluate tax positions in a two-step process. We first determine whether it is more likely than not that a tax position will be sustained upon examination, based on the technical merits of the position. If a tax position meets the more-

likely-than-not recognition threshold, it is then measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. We classify gross interest and penalties and unrecognized tax benefits that are not expected to result in payment or receipt of cash within one year as long-term liabilities in the financial statements.

Revenue Recognition

Revenue Recognition:

Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

Step 1: Identify the contract(s) with customers.

Step 2: Identify the performance obligations in the contract.

Step 3: Determine the transaction price.

Step 4: Allocate the transaction price to performance obligations.

Step 5: Recognize revenue when the entity satisfies a performance obligation.

As the Company had no business operations during the three months period ended March 31, 2024 and 2023, we have not identified specific planned revenue streams.

During the three-month periods ended March 31, 2024 and 2023, we did not recognize any revenue.

Advertising Costs

Advertising Costs:

We expense advertising costs when advertisements occur. No advertising costs were incurred during the three-month periods ended March 31, 2024 or 2023.

Stock-Based Compensation

Stock-Based Compensation:

The cost of equity instruments issued to employees and non-employees in return for goods and services is measured by the grant date fair value of the equity instruments issued in accordance with ASC 718, Compensation – Stock Compensation. The related expense is recognized as services are rendered or vesting periods elapse.

Net Loss per Share Calculation

Net Loss per Share Calculation:

Basic earnings (loss) per common share ("EPS") is computed by dividing net income (loss) available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average shares outstanding, assuming all dilutive potential common shares were issued. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive.

Recently Accounting Pronouncements

Recently Accounting Pronouncements:

We have reviewed all the recently issued, but not yet effective, accounting pronouncements and do not believe any of these pronouncements will have a material impact on our financial statements.

v3.24.1.1.u2
Nature of Operations (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Nov. 17, 2022
Nature of Operations [Line Items]      
Description of reverse split a reverse split of the common stock issued and outstanding on a one new share for one million (1,000,000) old shares basis as of November 10, 2021. Fractional shares will be rounded up to the next whole share.    
Description of forward split a forward split of the common stock issued and outstanding as of November 10, 2021. Subsequent to the 1/1,000,000 reverse split described above, each share of post reverse split adjusted issued and outstanding Common Stock shall be forward split on a one for one hundred (100) basis such that each post reverse split old share represents 100 new shares. Fractional shares will be rounded up to the next whole share.    
Preferred stock, shares authorized 24,999,000 24,999,000  
Series A preferred stock, description Forward split each share of issued and outstanding Series A Preferred Stock as of record date November 25, 2022 in the ratio of 1:1,000    
New shares 1,000    
Preferred Stock, conversion Convert 499 post-split shares of Series A Preferred Stock into 9,130,995,911 shares of our common stock leaving 501 shares of post-split Series A stock issued and outstanding.    
CECI [Member]      
Nature of Operations [Line Items]      
Partial repayment of the outstanding fees due $ 5,000    
Final settlement of the outstanding fees due 30,000    
Initial fee payment 5,000    
CECI [Member] | Mr. Cutler [Member]      
Nature of Operations [Line Items]      
Final settlement of the outstanding fees due $ 35,000    
Series A Preferred Stock [Member]      
Nature of Operations [Line Items]      
Preferred stock voting rights 61%    
Preferred stock, shares authorized 1,000 1,000  
Series A Preferred Stock [Member] | Board of Director [Member] | Minimum [Member]      
Nature of Operations [Line Items]      
Preferred stock, shares authorized     1
Series A Preferred Stock [Member] | Board of Director [Member] | Maximum [Member]      
Nature of Operations [Line Items]      
Preferred stock, shares authorized     1,000
Series B Preferred Stock [Member] | Board of Director [Member]      
Nature of Operations [Line Items]      
Preferred stock, shares unissued     24,999,999
v3.24.1.1.u2
Going Concern (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Going Concern [Abstract]      
Net Income (Loss) $ (15,680) $ (27,279)  
Accumulated deficit $ (31,161,535)   $ (31,145,855)
v3.24.1.1.u2
Summary of Significant Accounting Policies (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]    
Cash balances $ 0 $ 0
Membership interest percentage 10.00%  
Ultimate settlement percentage 50.00%  
v3.24.1.1.u2
Accounts Payable and Accruals (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Accounts Payable [Abstract]    
Accounts payable and accruals $ 1,855 $ 1,600
v3.24.1.1.u2
Accruals - Related Parties (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Related Party [Member]    
Accrued Expenses - Related Parties [Line Items]    
Accruals - related parties $ 249,000 $ 234,000
Current Controlling Shareholder, Director and Chief Financial Officer [Member]    
Accrued Expenses - Related Parties [Line Items]    
Accruals - related parties 170,000 79,000
Former Controlling Shareholder [Member]    
Accrued Expenses - Related Parties [Line Items]    
Accruals - related parties $ 155,000 $ 79,000
v3.24.1.1.u2
Note Payable – Related Party (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Note Payable – Related Party [Line Items]      
Promissory note $ 425 $ 13,954  
Related Party [Member]      
Note Payable – Related Party [Line Items]      
Notes payable - related party $ 104,931   $ 104,506
v3.24.1.1.u2
Shareholders’ Deficit (Details)
1 Months Ended 3 Months Ended
Nov. 10, 2021
shares
Nov. 25, 2022
shares
Mar. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Nov. 17, 2022
shares
May 29, 2021
USD ($)
shares
Jul. 27, 2015
shares
Shareholders' Deficit [Line Items]              
Preferred stock, shares authorized     24,999,000 24,999,000      
Preferred stock par value (in Dollars per share) | $ / shares     $ 0.00001 $ 0.00001      
Voting rights, percentage     61.00%        
Preferred stock issued value (in Dollars) | $          
Reverse split description     Following the 1: 1,000 forward split effective November 25, 2022, each one of the 1,000 post forward split shares of Series A Preferred Stock is now convertible into 18,298,589 shares of common stock with total voting rights equal to 76% ownership of the common stock of the Company at the option of the Holder.        
Common stock authorized     15,000,000,000 15,000,000,000      
Common stock par value (in Dollars per share) | $ / shares     $ 0.00001 $ 0.00001      
Common stock, shares issued     14,981,701,785 14,981,701,785      
Common stock, shares outstanding     14,981,701,785 14,981,701,785      
Minimum [Member]              
Shareholders' Deficit [Line Items]              
Reverse share split 1            
Forward share split 1            
Maximum [Member]              
Shareholders' Deficit [Line Items]              
Reverse share split 1,000,000            
Forward share split 100            
Series A Preferred Stock [Member]              
Shareholders' Deficit [Line Items]              
Preferred stock, shares authorized     1,000 1,000      
Preferred stock par value (in Dollars per share) | $ / shares     $ 0.00001 $ 0.00001      
Preferred stock, shares designated             1
Convertible common shares     1,000        
Voting rights, percentage     61.00%        
Preferred stock returned           1  
Preferred stock issued value (in Dollars) | $     $ 19,990 $ 19,990   $ 39,900  
Preferred stock new shares   1,000          
Preferred Stock, conversion     Effective November 25, 2022, 499 shares of Series A Preferred Stock was converted into 9,130,995,911 shares of common stock and the remaining 501 shares are issued and outstanding as on March 31, 2024.        
Preferred stock, shares issued     501 501      
Preferred stock, shares outstanding     501 501      
Series A Preferred Stock [Member] | Minimum [Member]              
Shareholders' Deficit [Line Items]              
Preferred Stock outstanding split ratio   1          
Voting power of the single share     61.00%        
Series A Preferred Stock [Member] | Maximum [Member]              
Shareholders' Deficit [Line Items]              
Preferred Stock outstanding split ratio   1,000          
Voting power of the single share     68.00%        
Series A Preferred Stock [Member] | Board of Director [Member] | Minimum [Member]              
Shareholders' Deficit [Line Items]              
Preferred stock, shares authorized         1    
Series A Preferred Stock [Member] | Board of Director [Member] | Maximum [Member]              
Shareholders' Deficit [Line Items]              
Preferred stock, shares authorized         1,000    
Series B Preferred Stock [Member]              
Shareholders' Deficit [Line Items]              
Preferred stock, shares designated             24,999,999
Convertible common shares     501 501      
Series B Preferred Stock [Member] | Board of Director [Member]              
Shareholders' Deficit [Line Items]              
Preferred stock, shares unissued         24,999,999    
Common Stock [Member]              
Shareholders' Deficit [Line Items]              
Common stock authorized     15,000,000,000        
Common stock par value (in Dollars per share) | $ / shares     $ 0.00001        
Series A Preferred Stock One [Member]              
Shareholders' Deficit [Line Items]              
Convertible common shares   9,130,995,911          
Preferred stock, shares issued   499          
Preferred Stock [Member]              
Shareholders' Deficit [Line Items]              
Preferred stock, shares authorized     25,000,000        
Preferred stock par value (in Dollars per share) | $ / shares     $ 0.00001        
null
Atlas Technology (PK) (USOTC:ATYG)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos Atlas Technology (PK).
Atlas Technology (PK) (USOTC:ATYG)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos Atlas Technology (PK).